CAS: 354812-41-2; 1-Cyclopropyl-6-Fluoro-8-Methoxy-7-(Octahydro-6H-Pyrrolo[3,4-B]Pyridin-6-yl)-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid

该化合物是一种合成有机化合物,其特征是其复杂的分子结构,包括一种与环丙基和西洛洛西里丁混合物结合的quinline核心,这种化合物展示了quinoline衍生物的典型特性,例如潜在的生物活动,使其对药用化学感兴趣.一个氟丙酮原子和甲氧基化合物组的存在表明,它具有强化的亲脂性和可能调和药性特性.

结构式图片

上下游产品

1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid (1S,6S)-2,8-diazabicyclo[4.3.0]nonane 3,O4-bis(propyloxy-O)borate1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline-carboxylic acid O3,O4-bis(propyloxy-O)borate moxifloxacin hydr°Chloride methyl 1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-°Ctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate N-methylmoxifloxacin 7-amino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxoquinoline-3-carboxylic acid 1-cyclopropyl-7-{(S,S)-2,8-diazabicyclo[4.3.0]non-8-yl}-6-fluoro-8-hydroxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:WO-2012131629-A1
    优先权日:2011-03-31
    标题 :A process for preparation of intermediate of moxifloxacin
    发明人:WANKHEDE KARUNA; JAGTAP ASHUTOSH; ROY MITA; HARIHARAN SIVARAMAKRISHNAN; KUMBHAR AJAY
    权利人:PIRAMAL HEALTHCARE LTD; WANKHEDE KARUNA; JAGTAP ASHUTOSH; ROY MITA; HARIHARAN SIVARAMAKRISHNAN; KUMBHAR AJAY
    摘要:The present invention provides a process for the preparation of racemic or chiral octahydro-6-(phenylmethyl)-1H-pyrrolo[3,4-b]pyridine of formula I, a key intermediate in the synthesis of moxifloxacin or its pharmaceutically acceptable salts. The process comprises reaction of racemic or chiral tetrahydro-6-(phenylmethyl)-1H- pyrrolo[3,4-b]pyridine-5,7(6H)-dione of formula II with a reducing agent, which is a mixture of two agents, that is mixture of dimethyl sulphate and sodium borohydride or aluminum chloride and sodium borohydride used in a molar ratio ranging from 1:1 to 1: 4, in the presence of a polar solvent at a temperature ranging from 15°C to 45°C 10 to obtain racemic or chiral octahydro-6-(phenylmethyl)-1H-pyrrolo[3,4-b]pyridine of formula I having purity ≥ 96%.

    专利号:US-9908876-B2
    优先权日:2009-11-05
    标 题:Imidazo [1,2-a]pyridine compounds, synthesis thereof, and methods of using same
    发明人:MILLER MARVIN J; MORASKI GARRETT C; MARKLEY LOWELL D; DAVIS GEORGE E
    权利人:UNIV NOTRE DAME DU LAC
    摘要:Embodiments relate to the field of chemistry and biochemistry, and, more specifically, to imidazopyridine compounds, synthesis thereof, and methods of using same. Disclosed herein are various imidazo[1,2-a]pyhdine compounds and methods of using the novel compounds to treat or prevent tuberculosis in a subject or to inhibit fungal growth on plant species. Other embodiments include methods of synthesizing imidazo[1,2-a]pyridine compounds, such as the disclosed imidazo[1,2-a]pyridine compounds.

    专利号:WO-2010100215-A1
    优先权日:2009-03-06
    标题:SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLO[3,4-b]PYRIDINE

    专利号:KR-20150048920-A
    优先权日:2006-11-13
    标 题 :Process for the synthesis of moxifloxacin hydrochloride

    专利号:US-2016318925-A1
    优先权日:2009-11-05
    标题:IMIDAZO [1,2-a]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING SAME

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S10 | SWISSPHARMA | Pharmaceutical List with Consumption Data | DOI:10.5281/zenodo.2623484
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知